Individualized treatment of osteoporosis

被引：0

作者：

Harbeck, B. ^{[1
]}

Lehnert, H. ^{[2
]}

机构：

[1] Univ Lubeck, Med Klin 1, Univ Klinikum Schleswig Holstein, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany

[2] Univ Lubeck, Prasidium, Lubeck, Germany

来源：

INTERNIST | 2016年 / 57卷 / 07期

关键词：

Osteoporosis; drug therapy; Age factors; Comorbidity; Risk assessment; Fracture prophylaxis; BONE-MINERAL DENSITY; VERTEBRAL FRACTURE RISK; POSTMENOPAUSAL WOMEN; ZOLEDRONIC ACID; BISPHOSPHONATES; DENOSUMAB; TERIPARATIDE; EFFICACY; ALENDRONATE; PREVENTION;

D O I：

10.1007/s00108-016-0074-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Osteoporosis is the most common clinical disorder of bone metabolism. Treatment decisions should be made on an individual basis, taking into consideration the relative benefits and risks in different patient populations. Drug selection should be based on the form (primary/secondary) and severity of osteoporosis, age, sex, the specific contraindications and precautions for using the various available medications, and existing comorbidities.

引用

页码：638 / +

页数：7

共 50 条

[31] Sequential treatment in osteoporosis. New trends
Casado, E.
Neyro, J. L.
REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2021, 13 (04) : 107 - 116
[32] Advances in treatment of glucocorticoid-induced osteoporosis
Hsu, Emory
Nanes, Mark
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (06) : 411 - 417
[33] Insights into the Mechanism of Osteoporosis and the Available Treatment Options
Muniyasamy, Rajeshwari
Manjubala, Inderchand
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024, 25 (12) : 1538 - 1551
[34] Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
Minisola, Salvatore
Cipriani, Cristiana
Della Grotta, Giada
Colangelo, Luciano
Occhiuto, Marco
Biondi, Piergianni
Sonato, Chiara
Vigna, Evelina
Cilli, Mirella
Pepe, Jessica
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2019, 11
[35] Alendronate for Effective Treatment of Male Osteoporosis : An Insight
Al Lawati, Hanan
Al Busaidi, Sara
Al Rawahi, Thuraiya
Al Lawati, Abdullah
Kifah, Ahmed
Das, Srijit
CURRENT PHARMACEUTICAL DESIGN, 2025, 31 (01) : 26 - 36
[36] A holistic hip fracture approach: individualized diagnosis and treatment after surgery
Amling, M.
Oheim, R.
Barvencik, F.
EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY, 2014, 40 (03) : 265 - 271
[37] Pharmacological Management of Osteoporosis in Postmenopausal Women: The Current State of the Art
Gatti, Davide
Fassio, Angelo
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2019, 26 (04): : E1 - E17
[38] Drug treatment of osteoporosis
Fassbender, W. J.
Willmann, B.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (10) : 497 - 500
[39] The Treatment Gap in Osteoporosis
Ayub, Nazia
Faraj, Malak
Ghatan, Sam
Reijers, Joannes A. A.
Napoli, Nicola
Oei, Ling
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
[40] Romosozumab in the treatment of osteoporosis
Kobza, Alexandra O.
Papaioannou, Alexandra
Lau, Arthur N.
Adachi, Jonathan D.
IMMUNOTHERAPY, 2020, 12 (13) : 965 - 981

← 1 2 3 4 5 →